Basel, Switzerland

Michael Bauer

This inventor holds 2 USPTO granted patents. Top assignee: Cellestia Biotech Ag. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Bauer. Retrieved from https://idiyas.com/inventor/michael-bauer-gkgjew1d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Bauer - Innovator in Amino Diaryl Ethers

Introduction

Michael Bauer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of amino diaryl ethers. With a total of two patents to his name, Bauer's work is recognized for its innovative approaches and practical applications.

Latest Patents

Bauer's latest patents focus on a process for making amino diaryl ethers and their hydrochloride salts. The invention involves reducing a compound with hydrogen in the presence of a palladium catalyst and a solvent, which can be a polar, aprotic solvent or a C3-C10 alcohol. This process not only enhances the efficiency of producing these compounds but also includes the creation of hydrochloride and monohydrochloride salts of the amino diaryl ethers.

Career Highlights

Michael Bauer is currently associated with Cellestia Biotech AG, where he continues to push the boundaries of chemical innovation. His work has been instrumental in advancing the understanding and production of complex chemical compounds.

Collaborations

Bauer collaborates with esteemed colleagues such as Uwe Hahn and Erhard Bappert. Their combined expertise fosters a productive environment for research and development in the biotech sector.

Conclusion

Michael Bauer's contributions to the field of chemistry, particularly through his patents on amino diaryl ethers, highlight his role as an influential inventor. His ongoing work at Cellestia Biotech AG promises to yield further advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…